To test this hypothesis, we investigated: (i) the efficacy of ATM and ATR kinase inhibitors on cyst growth in vitro; and (ii) the progression of cystic kidney disease in Pkd1RC/RC mice (genetic ortholog of ADPKD) with heterozygous or homozygous genetic deletion of Atm [25]. This evidence concerns the gene ATM and cystic kidney disease.